Senovia Biosciences is pioneering Metabolic Therapeutics, a transformative new class of medicines designed to address unmet needs in rare, neurodegenerative, and metabolic diseases.
Our approach redefines how we treat complex conditions—opening a new frontier in human health.
Learn more about our pipeline
-
Cuts Aβ / p-Tau ~50 % and restores memory to near-wild-type in 3×Tg-AD mice; rescues 95 % viability in human iPSC-AD neurons.
-
Drives −22 % body-weight drop and −50 % fat mass via higher energy expenditure while fully preserving lean mass.
-
Fully rescues hippocampal LTP, restores motor learning, and cuts seizures ~48 % in Ube3a-/- mice.